SeaStar Medical (NASDAQ:ICU) versus Straumann (OTCMKTS:SAUHY) Head-To-Head Comparison

Straumann (OTCMKTS:SAUHY) and SeaStar Medical (NASDAQ:ICU) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, analyst recommendations, dividends, valuation, risk, institutional ownership and earnings.

Valuation and Earnings

This table compares Straumann and SeaStar Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Straumann	$3.14 billion	6.37	$429.59 million	N/A	N/A
SeaStar Medical	$1.23 million	11.40	-$12.15 million	($4.80)	-0.66

Straumann has higher revenue and earnings than SeaStar Medical.

Insider and Institutional Ownership

1.7% of SeaStar Medical shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

Straumann has a beta of 1.58, indicating that its stock price is 58% more volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.05, indicating that its stock price is 205% less volatile than the S&P 500.

Profitability

This table compares Straumann and SeaStar Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Straumann	N/A	N/A	N/A
SeaStar Medical	-795.51%	-162.75%	-109.89%

Analyst Recommendations

This is a summary of current recommendations and price targets for Straumann and SeaStar Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Straumann	2	2	3	0	2.14
SeaStar Medical	1	0	1	0	2.00

SeaStar Medical has a consensus price target of $8.00, indicating a potential upside of 151.57%. Given SeaStar Medical’s higher probable upside, analysts plainly believe SeaStar Medical is more favorable than Straumann.

Summary

Straumann beats SeaStar Medical on 8 of the 12 factors compared between the two stocks.

About Straumann

Straumann Holding AG provides tooth replacement and orthodontic solutions worldwide. It researches, develops, manufactures, and supplies dental implants, instruments, CADCAM prosthetics, orthodontic aligners, biomaterials, and digital solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. The company offers dental implants and components made from titanium, titanium alloy, and ceramics; prosthetic elements made od ceramics, metal or polymer; and clear aligners. In addition, it offers resins for 3D printing and thermoplastics for clear aligner production; and biomaterials for tissue generation. Further, it provides digital equipment comprising scanners, milling machines and 3D printers. Further, it offers training and education services. The company provides its products to general dentists, specialists, and dental technicians and laboratories, as well as customers, such as distributors, hospitals, universities, and dental service organizations in approximately 100 countries through a network of distribution subsidiaries and partners. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.